Ignite Creation Date:
2024-05-06 @ 4:03 AM
Last Modification Date:
2024-10-26 @ 11:43 AM
Study NCT ID:
NCT02449889
Status:
COMPLETED
Last Update Posted:
2019-06-26
First Post:
2015-05-18
Brief Title:
A Randomised Trial Using Highly Purified Human Chorionic Gonadotropin HP-hCG and Recombinant Human Chorionic Gonadotropin rhCG in Women Undergoing Controlled Ovarian Stimulation
Sponsor:
Ferring Pharmaceuticals
Organization:
Ferring Pharmaceuticals
Study Overview
Official Title:
A Randomised Controlled Assessor-blind Parallel Groups Multicentre Trial Comparing the Efficacy and Safety of Highly Purified Human Chorionic Gonadotropin HP-hCG and Recombinant Human Chorionic Gonadotropin rhCG for Triggering of Final Follicular Maturation in Women Undergoing Controlled Ovarian Stimulation
Status:
COMPLETED
Status Verified Date:
2019-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
FASHION
Brief Summary:
This trial is investigating the efficacy and safety of highly purified human chorionic gonadotropin HP-hCG and recombinant human chorionic gonadotropin rhCG for triggering of final follicular maturation in women undergoing controlled ovarian stimulation
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None